Antipsychotic Drugs Market Size, Share & Trends Analysis Report By Class (First Generation, Second Generation, Third Generation), By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Others), By Drug Outlook (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 23, 2026 | Author: Debashree B | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Antipsychotic Drugs Market Size Analysis
    1. Introduction
    2. Antipsychotic Drugs Market Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
      1. First Generation
      2. Second Generation
      3. Third Generation
    3. Antipsychotic Drugs Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. Schizophrenia
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    4. Antipsychotic Drugs Market Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    5. Antipsychotic Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  7. North America Antipsychotic Drugs Market Size Analysis
    1. Introduction
    2. Antipsychotic Drugs Market Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
      1. First Generation
      2. Second Generation
      3. Third Generation
    3. Antipsychotic Drugs Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. Schizophrenia
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    4. Antipsychotic Drugs Market Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    5. Antipsychotic Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  8. Europe Antipsychotic Drugs Market Size Analysis
    1. Introduction
    2. Antipsychotic Drugs Market Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
      1. First Generation
      2. Second Generation
      3. Third Generation
    3. Antipsychotic Drugs Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. Schizophrenia
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    4. Antipsychotic Drugs Market Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    5. Antipsychotic Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. France
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  9. APAC Antipsychotic Drugs Market Size Analysis
    1. Introduction
    2. Antipsychotic Drugs Market Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
      1. First Generation
      2. Second Generation
      3. Third Generation
    3. Antipsychotic Drugs Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. Schizophrenia
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    4. Antipsychotic Drugs Market Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    5. Antipsychotic Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. China
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. India
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  10. Middle East and Africa Antipsychotic Drugs Market Size Analysis
    1. Introduction
    2. Antipsychotic Drugs Market Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
      1. First Generation
      2. Second Generation
      3. Third Generation
    3. Antipsychotic Drugs Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. Schizophrenia
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    4. Antipsychotic Drugs Market Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    5. Antipsychotic Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  11. LATAM Antipsychotic Drugs Market Size Analysis
    1. Introduction
    2. Antipsychotic Drugs Market Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
      1. First Generation
      2. Second Generation
      3. Third Generation
    3. Antipsychotic Drugs Market Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
      1. Schizophrenia
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    4. Antipsychotic Drugs Market Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    5. Antipsychotic Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Class 2022-2034 (USD MILLION/ Units)
        1. First Generation
        2. Second Generation
        3. Third Generation
      3. Market Size & Forecast By Disease 2022-2034 (USD MILLION/ Units)
        1. Schizophrenia
        2. Bipolar Disorder
        3. Unipolar Depression
        4. Dementia
        5. Others
      4. Market Size & Forecast By Drug Outlook 2022-2034 (USD MILLION/ Units)
        1. Risperidone
        2. Quetiapine
        3. Olanzapine
        4. Aripiprazole
        5. Brexpiprazole
        6. Paliperidone Palmitate
        7. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  12. Competitive Landscape
    1. Antipsychotic Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Otsuka Pharmaceutical Co., Ltd. (Japan)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Johnson & Johnson (US)
    3. Bristol Myers Squibb (US)
    4. AbbVie Inc. (US)
    5. Eli Lilly and Company (US)
    6. Pfizer Inc. (US)
    7. AstraZeneca plc (UK)
    8. Sumitomo Pharma Co., Ltd. (Japan)
    9. Teva Pharmaceutical Industries Ltd. (Israel)
    10. Viatris Inc. (US)
    11. Lundbeck A/S (Denmark)
    12. Alkermes plc (Ireland)
    13. Neurocrine Biosciences, Inc. (US)
    14. Intra-Cellular Therapies, Inc. (US)
    15. Boehringer Ingelheim GmbH (Germany)
    16. Sun Pharmaceutical Industries Ltd. (India)
    17. Reddy’s Laboratories Ltd. (India)
    18. Aurobindo Pharma Ltd. (India)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

We are featured on: